You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non-resectable

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Intrahepatic Cholangiocarcinoma Trial in Padova (Liver transplantation)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Liver transplantation
  • Padova, Italy
    Azienda Ospedale Università di Padova
Oct 25, 2023

Perihilar Cholangiocarcinoma Trial in Padova (Liver transplantation)

Not yet recruiting
  • Perihilar Cholangiocarcinoma
  • Liver transplantation
  • Padova, Italy
    Azienda Ospedale Università di Padova
Nov 5, 2023

Pancreas Cancer, Non-Resectable Pancreas Carcinoma Trial in Aalborg (Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreas Cancer
  • Non-Resectable Pancreas Carcinoma
  • Aalborg, Denmark
    Department of Oncology, Aalborg University Hospital
May 1, 2023

Hepatocellular Carcinoma Trial in Munich, Würzburg (durvalumab, tremelimumab, bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • durvalumab, tremelimumab, bevacizumab
  • Munich, Germany
  • +2 more
May 3, 2023

Intrahepatic Cholangiocarcinoma Trial in Oslo (Liver Transplant)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Liver Transplant
  • Oslo, Norway
    Oslo University Hospital
Oct 4, 2022

Viewpoints on Social Representations and Rationale Concerning

Terminated
  • Non-resectable Metastatic Cancer of the Lung
  • +7 more
  • Interviews
  • Questionnaires
  • Dijon, France
    Chu Dijon Bourogne
Apr 14, 2022

Hepatocellular Carcinoma Trial in France (QuiremSpheres)

Recruiting
  • Hepatocellular Carcinoma
  • QuiremSpheres
  • Clichy, France
  • +3 more
Jan 27, 2023

Sarcoma Trial in Turin (Autologous CIK)

Recruiting
  • Sarcoma
  • Autologous CIK
  • Turin, Italy
    AOU Città della Salute e della Scienza di Torino - Presidio Infa
Aug 11, 2022

NSCLC Trial in Chongqing (procedure, drug, radiation)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • bronchial artery interventional therapy
  • +3 more
  • Chongqing, Chongqing, China
    Daping Hospital, Third Military Medical University
May 27, 2023

Colorectal Cancer, Liver Metastases, Genetic Change Trial in Barcelona (Liver transplantation)

Recruiting
  • Colorectal Cancer
  • +2 more
  • Liver transplantation
  • Barcelona, Spain
    Department of HPB Surgery and Transplants, Hospital Vall d´Hebro
Jun 13, 2022

Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours Trial in Worldwide (lanreotide, Placebo)

Terminated
Has Results
  • Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours
  • Bruxelles, Belgium
  • +23 more
Dec 21, 2022

Hepatocellular Carcinoma Non-resectable Trial (Selective Internal Radiation Therapy with 188Re-SSS lipiodol)

Not yet recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Selective Internal Radiation Therapy with 188Re-SSS lipiodol
  • (no location specified)
Mar 22, 2023

Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • +12 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 30, 2022

Pancreatic Cancer Non-resectable Trial (collection of blood and tumor samples)

Not yet recruiting
  • Pancreatic Cancer Non-resectable
  • collection of blood and tumor samples
  • (no location specified)
Mar 27, 2023

Hepatocellular Carcinoma Non-resectable Trial in Taoyuan City (Atezolizumab, Bevacizumab, Proton radiotherapy)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Taoyuan City, Taiwan
    Chang Gung Memorial Hospital at Linkou
Nov 17, 2023

NSCLC Trial in Beijing

Recruiting
  • NSCLC
    • Beijing, China
      Yuyan Wang
    Oct 10, 2023

    HER2 Positive Non Resectable or Metastatic Breast Cancer Trial (SHR-A1811:Pyrroltinib, SHR-A1811;Pertuzumab, SHR-A1811;SHR-1316)

    Not yet recruiting
    • HER2 Positive Non Resectable or Metastatic Breast Cancer
    • (no location specified)
    Apr 25, 2022

    Lung Cancer Trial (Sacituzumab Govitecan, Pembrolizumab)

    Not yet recruiting
    • Lung Cancer
    • (no location specified)
    Sep 20, 2023

    Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

    Not yet recruiting
    • Stage II-IIIB(N2) Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Oct 26, 2023

    Liver Metastasis Colon Cancer, Colorectal Cancer Trial in Bologna (Liver Transplantation)

    Recruiting
    • Liver Metastasis Colon Cancer
    • Colorectal Cancer
    • Liver Transplantation
    • Bologna, Italy
      IRCCS Azienda Ospedaliero - Universitaria di Bologna
    Jan 7, 2022

    Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer Trial (EYE90 Microspheres Treatment)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • +2 more
    • EYE90 Microspheres Treatment
    • (no location specified)
    Jul 12, 2023

    Cholangiocarcinoma Non-resectable Trial in Chengdu (Candonilimab, Cisplatin, Gemcitabine)

    Recruiting
    • Cholangiocarcinoma Non-resectable
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Aug 4, 2023

    NSCLC Trial (Durvalumab)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • (no location specified)
    Jun 22, 2023

    Stage III NSCLC Trial (Toripalimab, JS004, Pemetrexed)

    Not yet recruiting
    • Stage III Non-small Cell Lung Cancer
    • (no location specified)
    Jun 3, 2023

    Resectable Stage II-IIIB Driver Gene-negative Non-small Cell

    Not yet recruiting
    • NSCLC
      • Changsha, Hunan, China
        Hunan Cancer Hospital
      Aug 6, 2023